Non-coding RNAs as biomarkers of myocardial infarction-Reference-Cited by-同舟云学术

Non-coding RNAs as biomarkers of myocardial infarction

Published:2023-02 Issue: Volume:540 Page:117222
ISSN:0009-8981
Container-title:Clinica Chimica Acta
language:en
Short-container-title:Clinica Chimica Acta

Author:

Almaghrbi Heba,Giordo Roberta,Pintus Gianfranco^ORCID,Zayed Hatem

Funder

Sardegna Foundation

University of Sassari

Publisher

Elsevier BV

Subject

Biochemistry (medical),Clinical Biochemistry,Biochemistry,General Medicine

Reference125 articles.

1. Glycogen synthase kinase 3 beta inhibitor SB216763 improves Kir2.1 expression after myocardia infraction in rats;Chang;J. Interv. Card Electrophysiol.,2022

2. The Roles of lncRNA in myocardial infarction: molecular mechanisms, diagnosis biomarkers, and therapeutic perspectives;Xie;Front. Cell. Dev. Biol.,2021

3. Oestrogen receptor β activation protects against myocardial infarction via notch1 signalling;Du;Cardiovasc. Drugs Ther.,2020

4. Long non-coding RNAs in cardiovascular diseases: potential function as biomarkers and therapeutic targets of exercise training, noncoding;Correia;RNA,2021

5. The rational clinical examination. Is this patient having a myocardial infarction?;Panju;JAMA,1998

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. microRNA 21 and long non-coding RNAs interplays underlie cancer pathophysiology: A narrative review;Non-coding RNA Research;2024-09

2. Ispinesib Mesylate-induced oxidative stress via miR-30e-5p/BCL2L11 axis in acute myocardial infarction: a comprehensive bioinformatics and experimental validation investigation;2024-08-01

3. MicroRNA-330-5p Mediates the TDRG1-Regulated Myocardial Inflammation and Apoptosis after Myocardial Infarction by Inhibiting MAPK1;International Heart Journal;2024-07-31

4. Search for predictors of complications of acute coronary syndrome with ST segment elevation – protocol of a prospective open cohort study PROMETHEUS;The Siberian Journal of Clinical and Experimental Medicine;2024-04-04

5. MG53: A new protagonist in the precise treatment of cardiomyopathies;Biochemical Pharmacology;2024-04